Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • How big is the problem?
    • How we drive change
    • Our story
  • Featured insights
    • The latest at the Foundation
    • The latest at the Foundation
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • Become a catalyst
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
  • Achievements so far
    • The Foundation's impact
    • The Foundation's impact
  • News
  • Our team
  • Our impact
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us
Achievements so far

The Foundation's impact

Through our tried-and-tested model for stimulating essential healthcare companies to do more to reach people in low- and middle-income countries, the Access to Medicine Foundation has had a demonstrable impact on expanding access to medicine.
Case study

How our research findings trigger change

14 November 2022
Event

Closing the gaps in access to diabetes care in low- and middle-income countries

07 July 2022
Case study

AMR Register: A global AMR surveillance data sharing platform

14 November 2022
Featured News

7 lessons from COVID-19 for pharma companies

13 July 2021

Our Engagement

202
Investors
51
Companies
152
Academic institutions
50
Global health organisations
Research

Spotlight on pharmaceutical companies’ actions in women’s health and SRHR

25 May 2022
Case study

Pfizer's 'Accord for a Healthier World'

28 October 2022
Featured News

Foundation welcomes new tool to tackle AMR by enhancing stewardship and access plans

22 March 2021

When I talk to executives from pharmaceutical companies they tell me that they want to do more for neglected diseases, but they at least need to get credit for it. The Access to Medicine Index does exactly that.

Photo of: Bill Gates

Bill Gates

Co-chair and Trustee, Bill & Melinda Gates Foundation

Featured Case study

How companies demonstrate movement on key opportunities identified by our research: Sanofi Global Health Unit

10 November 2022
News

Global oxygen suppliers commit to closing oxygen gaps in low- and middle-income countries

16 June 2021
Media

Pfizer to offer all its drugs not-for-profit to 45 lower-income countries

25 May 2022

Margo Warren

Director of Government Engagement & Policy

mwarren@Accesstomedicinefoundation.org

Get in touch

Explore our research sectors

Big Pharma

We influence and encourage them to make their products accessible for all.

Discover more

Generic medicine manufacturers

We empower the industry to become more responsive.

Discover more

Medical gas companies

We stimulate the industry to ensure availability for treatments and procedures.

Discover more

Diagnostic companies

We forge partnerships to unlock the potential of diagnostics.

Discover more

Vaccine manufacturers

We guide them to improve access to immunisation.

Discover more

The Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Copyright 2004 - 2022 Access to Medicine Foundation - All Rights Reserved